Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Acne Vulgaris Market Grown from 2024 to 2025?
The market size of acne vulgaris has experienced robust growth in the past few years. It is projected to expand from $7.94 billion in 2024 to approximately $8.47 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The previous growth can be traced back to an increased occurrence of acne, consumers favoring natural ingredients, proliferation of online retailing, investment into research and development, and a wider availability of over-the-counter products.
What Growth Rate Is Anticipated for the Acne Vulgaris Market in the Coming Years?
Anticipated robust expansion is in the forecast for the acne vulgaris market in the years to come. The market is projected to rise to a value of $10.89 billion by 2029, attaining a compound annual growth rate (CAGR) of 6.5%. This growth during the projected timeframe can be linked to factors such as increased skincare consciousness, the growing number of teenagers, an emphasis on self-care and well-being, a rise in adult acne cases, telemedicine, and the spread of e-commerce. The forecast period is also expected to see major trends such as technological progress, the introduction of sophisticated drugs, innovative product offerings, expanding clinical approval, and breakthroughs in unique medical procedures.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21075&type=smp
Who Are the Leading Companies in the Acne Vulgaris Market?
Major companies operating in the acne vulgaris market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., L’Oréal Paris, GlaxoSmithKline Plc., Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals, Bausch Healh Companies, Sun Pharmaceutical Industries Ltd., Incyte, Aurobindo Pharma, Lupin Ltd., Torrent Pharmaceuticals, Biocon, Stiefel Laboratories, Mayne Pharma Group Limited, Paratek Pharmaceuticals, Cosmo Pharmaceuticals, AOBiome
What Are the Key Drivers of the Acne Vulgaris Market?
Skincare product demand is predicted to boost the acne vulgaris market’s expansion in the future. Comprising a broad spectrum of items that cater to various skin woes, from hydration to shielding, skincare products are substances that aim to better the skin’s health and appearance. The rise in demand for these products is attributed to factors like the impact of social media, escalating skin issues, product evolution, and a shift in focus towards preventive skincare, all contributing to the growing skincare awareness. Skincare products that address the fundamental triggers of acne vulgaris, like surplus sebum production, blocked pores, and bacterial proliferation, lend support to acne treatment. This is done by the incorporation of ingredients such as salicylic acid, benzoyl peroxide, and retinoids, which facilitate skin exfoliation, minimise inflammation, and encourage the development of cleaner, healthier skin. For example, as per The Cosmetic, Toiletry and Perfumery Association (CTPA), a non-profit organisation based in the UK, the European cosmetics market in August 2024 was €96 billion (roughly $105 billion) at retail sales price (RSP) in 2023, making it one of the largest alongside the USA. This market witnessed growth from €88 billion (around $93 billion) RSP in 2022. Consequently, the heightened skincare awareness is fuelling the acne vulgaris market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21075&type=smp
What Are the Key Market Segments in the Acne Vulgaris Industry?
The acne vulgaris market covered in this report is segmented –
1) By Type: Systemic Therapy, Hormonal Therapy, Physical Treatment, Topical Combination Therapy, Other Types
2) By Age Group: 10 To 17 Years, 18 To 44 Years, 45 To 64 Years, 65 Years And Above
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Systemic Therapy: Oral Antibiotics, Oral Retinoids, Oral Anti-Inflammatory Agents
2) By Hormonal Therapy: Oral Contraceptives, Androgen Receptor Inhibitors
3) By Physical Treatment: Laser Therapy, Light-Based Therapy, Chemical Peels, Microdermabrasion
4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations, Benzoyl Peroxide And Antibiotic Combinations, Retinoid And Benzoyl Peroxide Combinations
5) By Other Types: Herbal And Natural Remedies, Biologic Therapies, Emerging Therapies
What Are the Latest Trends in the Acne Vulgaris Market?
Leading businesses in the acne vulgaris market are channeling their efforts to create novel solutions like the triple-combination topical treatment, which can be administered once daily for acne vulgaris. This particular formulation merges three active ingredients that generally target separate elements of a disorder, thus offering an augmented therapeutic impact on conditions like acne or psoriasis. Case in point, Bausch Health Companies Inc., a pharmaceutical enterprise based in Canada, landed the Food and Drug Administration’s (FDA) approval for Cabtreo (clindamycin phosphate, adapalene, and benzoyl peroxide) in October 2023. This topical gel, specifically designed for treating acne vulgaris in patients above 12 years of age, uniquely combines an antibiotic, a retinoid, and an antibacterial agent for effective treatment of acne lesions and preventing potential breakouts. With Cabtreo, patients get a user-friendly application process, along with an advantageous safety profile that suits a broad spectrum of patients.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/acne-vulgaris-global-market-report
What Are the Key Regional Markets in the Acne Vulgaris Industry?
North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acne vulgaris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21075
This Report Delivers Insight On:
1. How big is the acne vulgaris market, and how is it changing globally?
2. Who are the major companies in the acne vulgaris market, and how are they performing?
3. What are the key opportunities and risks in the acne vulgaris market right now?
4. Which products or customer segments are growing the most in the acne vulgaris market?
5. What factors are helping or slowing down the growth of the acne vulgaris market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model